Justin L. Hay

1.2k total citations
46 papers, 813 citations indexed

About

Justin L. Hay is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Anesthesiology and Pain Medicine. According to data from OpenAlex, Justin L. Hay has authored 46 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 11 papers in Public Health, Environmental and Occupational Health and 9 papers in Anesthesiology and Pain Medicine. Recurrent topics in Justin L. Hay's work include Pain Mechanisms and Treatments (19 papers), Pain Management and Opioid Use (6 papers) and Pharmaceutical studies and practices (5 papers). Justin L. Hay is often cited by papers focused on Pain Mechanisms and Treatments (19 papers), Pain Management and Opioid Use (6 papers) and Pharmaceutical studies and practices (5 papers). Justin L. Hay collaborates with scholars based in Netherlands, United States and United Kingdom. Justin L. Hay's co-authors include Geert Jan Groeneveld, Guido van Amerongen, Jason M. White, Felix Bochner, Andrew A. Somogyi, T.J. Semple, Albert Dahan, Pieter Siebenga, Richard P. Butt and Marieke L. de Kam and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of the American Society of Nephrology.

In The Last Decade

Justin L. Hay

43 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin L. Hay Netherlands 18 295 192 172 146 140 46 813
Richard C. Crist United States 22 191 0.6× 431 2.2× 274 1.6× 153 1.0× 170 1.2× 60 1.4k
Alexandra Doehring Germany 24 389 1.3× 358 1.9× 270 1.6× 151 1.0× 265 1.9× 36 1.6k
Nicolas Marie France 18 187 0.6× 407 2.1× 468 2.7× 69 0.5× 76 0.5× 49 870
Bradford D. Fischer United States 15 193 0.7× 215 1.1× 323 1.9× 67 0.5× 42 0.3× 36 645
Shih‐Hsien Lin Taiwan 16 63 0.2× 206 1.1× 115 0.7× 65 0.4× 50 0.4× 54 769
Manuel Feria Spain 18 244 0.8× 127 0.7× 173 1.0× 71 0.5× 164 1.2× 40 772
Emma Claire Phillips United Kingdom 12 670 2.3× 341 1.8× 326 1.9× 120 0.8× 31 0.2× 22 1.1k
Joan M. Bailey Canada 6 875 3.0× 56 0.3× 90 0.5× 308 2.1× 358 2.6× 7 1.2k
Joyce Kim United States 16 411 1.4× 171 0.9× 139 0.8× 55 0.4× 70 0.5× 41 835

Countries citing papers authored by Justin L. Hay

Since Specialization
Citations

This map shows the geographic impact of Justin L. Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin L. Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin L. Hay more than expected).

Fields of papers citing papers by Justin L. Hay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin L. Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin L. Hay. The network helps show where Justin L. Hay may publish in the future.

Co-authorship network of co-authors of Justin L. Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Justin L. Hay. A scholar is included among the top collaborators of Justin L. Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin L. Hay. Justin L. Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheung, S. Y. Amy, et al.. (2024). Pediatric oncology drug development and dosage optimization. Frontiers in Oncology. 13. 1235947–1235947. 3 indexed citations
2.
Cook, Anne, et al.. (2020). Streamlined approval of biosimilars: moving on from the confirmatory efficacy trial. Drug Discovery Today. 25(11). 1910–1918. 39 indexed citations
3.
Ali, Sahra, Dominik Karres, Justin L. Hay, et al.. (2019). The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia. The Oncologist. 24(5). e171–e179. 27 indexed citations
4.
Siebenga, Pieter, Guido van Amerongen, Justin L. Hay, et al.. (2019). Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Nav1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects. Clinical and Translational Science. 13(2). 318–324. 36 indexed citations
5.
Amerongen, Guido van, Marieke L. de Kam, Jasper Stevens, et al.. (2016). The use of a battery of pain models to detect analgesic properties of compounds: a two‐part four‐way crossover study. British Journal of Clinical Pharmacology. 83(5). 976–990. 27 indexed citations
6.
Groeneveld, Geert Jan, et al.. (2016). Measuring blood–brain barrier penetration using the NeuroCart, a CNS test battery. Drug Discovery Today Technologies. 20. 27–34. 50 indexed citations
7.
Hay, Justin L., et al.. (2016). No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery. European Journal of Pain. 21(3). 494–506. 6 indexed citations
8.
Huygen, Frank, et al.. (2016). Good inter-center reproducibility of quantification of the corneal subbasal nerve plexus using in vivo corneal confocal microscopy. 57(12). 1921–1921.
9.
Wilhelmus, Micha M.M., Justin L. Hay, Rob Zuiker, et al.. (2016). Effects of a single, oral 60 mg caffeine dose on attention in healthy adult subjects. Journal of Psychopharmacology. 31(2). 222–232. 27 indexed citations
10.
Roozekrans, Margot, et al.. (2014). Two Studies on Reversal of Opioid-induced Respiratory Depression by BK-channel Blocker GAL021 in Human Volunteers. Anesthesiology. 121(3). 459–468. 39 indexed citations
11.
Guan, Zheng, et al.. (2014). STABILITY ANALYSIS OF CLUSTERING OF NORRIS' VISUAL ANALOG SCALE. British Journal of Clinical Pharmacology. 78(4). 766–766. 1 indexed citations
12.
Chen, Xia, Gabriël E. Jacobs, Kimberly J. Nahon, et al.. (2014). The effects of the nonselective benzodiazepine lorazepam and the α23 subunit‐selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels. Clinical Pharmacology in Drug Development. 4(2). 149–154. 11 indexed citations
13.
Hoever, Petra, et al.. (2013). Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose Almorexant, an Orexin Receptor Antagonist, in Healthy Elderly Subjects. Journal of Clinical Psychopharmacology. 33(3). 363–370. 24 indexed citations
14.
Boom, Merel, Erik Olofsen, Justin L. Hay, et al.. (2013). Fentanyl Utility Function. Anesthesiology. 119(3). 663–674. 29 indexed citations
15.
Hoch, Matthias, Justin L. Hay, Petra Hoever, et al.. (2012). Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humans. European Neuropsychopharmacology. 23(2). 107–117. 18 indexed citations
16.
Cruz, Hans G., Petra Hoever, Justin L. Hay, et al.. (2010). P.1.c.032 Interaction study between almorexant, a dual orexin receptor antagonist, and desipramine in healthy male subjects. European Neuropsychopharmacology. 20. S253–S253. 1 indexed citations
17.
Hay, Justin L., et al.. (2009). Model of methadone-induced hyperalgesia in rats and effect of memantine. European Journal of Pharmacology. 626(2-3). 229–233. 11 indexed citations
18.
Athanasos, Peter, Aaron L. Farquharson, Peggy Compton, Peter J. Psaltis, & Justin L. Hay. (2008). Electrocardiogram Characteristics of Methadone and Buprenorphine Maintained Subjects. Journal of Addictive Diseases. 27(3). 31–35. 30 indexed citations
19.
Hay, Justin L., et al.. (2008). Hyperalgesia in Opioid-Managed Chronic Pain and Opioid-Dependent Patients. Journal of Pain. 10(3). 316–322. 123 indexed citations
20.
Hay, Justin L., Jason M. White, Felix Bochner, & Andrew A. Somogyi. (2008). Antinociceptive effects of high dose remifentanil in male methadone‐maintained patients. European Journal of Pain. 12(7). 926–933. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026